Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Boer

Showing results (661-670 of 719) with videos related to

Pageof 72
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 25, 2022
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trialLisa Vermij, Alicia Léon-Castillo, Naveena Singh, et al.
The Journal of Pathology|June 21, 2008
Stem cell factor as a novel diagnostic marker for early malignant germ cellsH Stoop, F Honecker, G J M van de Geijn, et al.
European Journal of Neurology|May 9, 2023
Decreased emotion recognition and reduced focus on facial hallmarks in behavioral variant frontotemporal dementia compared to primary psychiatric disorders and controlsJay L P Fieldhouse, Ellen H Singleton, Marie-Paule E van Engelen, et al.
The Lancet. Planetary Health|March 7, 2024
Environmental assessment of diets: overview and guidance on indicator choiceYlva Ran, Christel Cederberg, Malin Jonell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsSterre C M de Boer, Simon Ducharme, Chiara Fenoglio, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2017
Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer ConsortiumR J W van Kampen, B L T Ramaekers, D J A Lobbezoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial CancerNanda Horeweg, Remi A Nout, Ina M Jürgenliemk-Schulz, et al.
Journal of Alzheimer'S Disease : JAD|May 24, 2021
Clinical Phenotypes of Behavioral Variant Frontotemporal Dementia by Age at OnsetJay L P Fieldhouse, Flora T Gossink, Thomas C Feenstra, et al.
Frontiers in Aging Neuroscience|May 24, 2024
The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trialsJay L P Fieldhouse, Dirk N van Paassen, Marie-Paule E van Engelen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 26, 2026
Autonomic dysfunction and hypothalamic atrophy in frontotemporal dementia and primary psychiatric disordersYannick S S Timar, Marie-Paule Emilie van Engelen, Vikram Venkatraghavan, et al.
Pageof 72

Showing results (661-670 of 719) with videos related to

Sort By:
Pageof 72
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 25, 2022
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trialLisa Vermij, Alicia Léon-Castillo, Naveena Singh, et al.
The Journal of Pathology|June 21, 2008
Stem cell factor as a novel diagnostic marker for early malignant germ cellsH Stoop, F Honecker, G J M van de Geijn, et al.
European Journal of Neurology|May 9, 2023
Decreased emotion recognition and reduced focus on facial hallmarks in behavioral variant frontotemporal dementia compared to primary psychiatric disorders and controlsJay L P Fieldhouse, Ellen H Singleton, Marie-Paule E van Engelen, et al.
The Lancet. Planetary Health|March 7, 2024
Environmental assessment of diets: overview and guidance on indicator choiceYlva Ran, Christel Cederberg, Malin Jonell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsSterre C M de Boer, Simon Ducharme, Chiara Fenoglio, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2017
Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer ConsortiumR J W van Kampen, B L T Ramaekers, D J A Lobbezoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial CancerNanda Horeweg, Remi A Nout, Ina M Jürgenliemk-Schulz, et al.
Journal of Alzheimer'S Disease : JAD|May 24, 2021
Clinical Phenotypes of Behavioral Variant Frontotemporal Dementia by Age at OnsetJay L P Fieldhouse, Flora T Gossink, Thomas C Feenstra, et al.
Frontiers in Aging Neuroscience|May 24, 2024
The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trialsJay L P Fieldhouse, Dirk N van Paassen, Marie-Paule E van Engelen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 26, 2026
Autonomic dysfunction and hypothalamic atrophy in frontotemporal dementia and primary psychiatric disordersYannick S S Timar, Marie-Paule Emilie van Engelen, Vikram Venkatraghavan, et al.
Pageof 72